This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services E-mail this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My File Cabinet Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Web of Science (19) Citing Articles via Google Scholar Google Scholar Articles by Abramson, D. H. Articles by Ranjithan, M. Search for Related Content PubMed PubMed Citation Articles by Abramson, D. H. Articles by Ranjithan, M. Related Collections Ophthalmology Social Bookmarking                         What's this?

PEDIATRICS Vol. 112 No. 6 December 2003, pp. 1248-1255

Screening for Retinoblastoma: Presenting Signs as Prognosticators of Patient and Ocular Survival

David H. Abramson, MD, Katherine Beaverson, MS, Poorab Sangani, MD, Robin A. Vora, MD, Thomas C. Lee, MD, Hilary M. Hochberg, MD, James Kirszrot, MD and Murali Ranjithan, MD

From the Robert M. Ellsworth Ophthalmic Oncology Center, Department of Ophthalmology, New York Presbyterian Hospital–Weill Medical College of Cornell University, New York, New York

Objective. To correlate 3 common presenting signs of retinoblastoma with patient and ocular survival and to assess the efficacy of current pediatric screening practices for retinoblastoma.

Methods. A retrospective study was conducted of 1831 retinoblastoma patients from our center (1914–June 2000). Patient survival (excluding deaths from other primary neoplasms) and ocular survival (presenting eyes) rates were calculated and analyzed using the Kaplan-Meier method.

Results. Leukocoria correlated with excellent patient survival (>86%, 5 years) but poor ocular survival in unilateral (4%, 5 years) and bilateral patients (29%, 5 years). A total of 308 (19%) of 1654 patients presented with strabismus: patient survival was excellent (90%, 5 years), and ocular survival was poor (17%, 5 years) yet better than leukocoria. Patients who had a family history of retinoblastoma and were clinically screened for retinal tumors from birth were diagnosed younger (8 months of age) and earlier (Reese Ellsworth group 1 = 26 [58%] of 45) and had better ocular survival than nonscreened patients with a family history. More patients were initially detected by family/friends (1315 [80%] of 1632) than pediatricians (123 [8%] of 1632) or ophthalmologists (156 [10%] of 1632).

Conclusion. Most US children whose retinoblastoma is diagnosed initially present with leukocoria detected by a parent, despite routine pediatric screening for leukocoria via the red reflex test. Initial disease detection at the point of leukocoria or strabismus correlated with high patient survival rates and poor ocular survival rates for the presenting eye. Saving eyes and vision requires disease recognition before leukocoria, as demonstrated by the better ocular salvage rate among patients who had a positive family history and received clinical surveillance via early, routine dilated funduscopic examinations by an ophthalmologist.

---

Key Words: retinoblastoma • cancer • leukocoria • red reflex • strabismus

Abbreviations: RE, Reese-Ellsworth • AP, all patients • –FH, no family history of retinoblastoma • +FH, family history of retinoblastoma • SFH, screened family history • AAP, American Academy of Pediatrics

---

Received for publication Sep 19, 2002; Accepted Mar 19, 2003.

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R Batra, F Rowe, A Rowlands, and C Noonan Unilateral leucocoria in clinically normal eyes Br J Ophthalmol, April 1, 2009; 93(4): 556 - 557. [Full Text] [PDF]

				A. H. Weiss, J. P. Kelly, R. P. Kapur, and T. Pendergrass Retinal Function and Corresponding Pathology in Advanced Retinoblastoma Arch Ophthalmol, November 1, 2008; 126(11): 1507 - 1512. [Abstract] [Full Text] [PDF]

				W. G. Wilson and J. R. Serwint Retinoblastoma Pediatr. Rev., January 1, 2007; 28(1): 37 - 38. [Full Text] [PDF]

				M. Wallach, A. Balmer, F. Munier, S. Houghton, S. Pampallona, N. von der Weid, M. Beck-Popovic, and on behalf of the Swiss Pediatric Oncology Group an Shorter Time to Diagnosis and Improved Stage at Presentation in Swiss Patients With Retinoblastoma Treated From 1963 to 2004 Pediatrics, November 1, 2006; 118(5): e1493 - e1498. [Abstract] [Full Text] [PDF]

				B C Figueiredo, R Sandrini, G P Zambetti, R M Pereira, C Cheng, W Liu, L Lacerda, M A Pianovski, E Michalkiewicz, J Jenkins, et al. Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation J. Med. Genet., January 1, 2006; 43(1): 91 - 96. [Abstract] [Full Text] [PDF]

				P. Chevez-Barrios, M. Chintagumpala, W. Mieler, E. Paysse, M. Boniuk, C. Kozinetz, M. Y. Hurwitz, and R. L. Hurwitz Response of Retinoblastoma With Vitreous Tumor Seeding to Adenovirus-Mediated Delivery of Thymidine Kinase Followed by Ganciclovir J. Clin. Oncol., November 1, 2005; 23(31): 7927 - 7935. [Abstract] [Full Text] [PDF]

				Detecting Retinoblastoma: We Can Do Better Journal Watch (General), December 30, 2003; 2003(1230): 3 - 3. [Full Text]